Frontlight ResearchEarly access
Trial site
The University of Arizona Cancer Center-North Campus
- 12running trials
- 1closed trial
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Prostate cancer4 trials
- Liver and biliary tract cancer2 trials
- Metastatic breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 12 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting7 trials
- Active, not recruiting5 trials
- Completed1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- ALX Oncology Inc.1 trial
- Kyntra Bio1 trial
- Oryzon Genomics S.A.1 trial
- Pfizer1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Bladder cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026